The Dogged Pursuit of Sales Leads at All Costs Does More Harm Than Good

Creditsafe Study Finds 44% of US Sales Managers Would Still Pursue Prospects with Track Records of Late Payments & Poor Business Credit Scores ALLENTOWN, Pa., Jan. 19, 2023 /PRNewswire/ — Despite a rocky economic environment and the likelihood of a recession in 2023, nearly half (44%) of…

Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results

Company to Host Conference Call on Thursday, February 16, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif., Jan. 19, 2023 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic…

Octapharma stellt die Perspektiven von Patienten und Klinikern auf dem 16. Jahreskongress der European Association for Haemophilia and Allied Disorders (EAHAD) in den Mittelpunkt

LACHEN, Schweiz, 18. Januar 2023 /PRNewswire/ — Die Ersatztherapie mit Blutgerinnungsfaktor VIII ist seit über 30 Jahren die Hauptsäule der Therapie für Patienten mit schwerer Hämophilie A mit nachgewiesenen Vorteilen in Bezug auf die Blutungsprävention und die Gelenkgesundheit. Die…

Taylor Morrison Announces Date for Fourth Quarter 2022 Earnings Release and Webcast Conference Call

SCOTTSDALE, Ariz., Jan. 18, 2023 /PRNewswire/ — Taylor Morrison Home Corporation (NYSE: TMHC) (“Taylor Morrison”), a leading national developer and homebuilder, announced today that it will release its fourth quarter 2022 results before the market opens on Wednesday, February 15, 2023….

Octapharma mettra le point de vue des patients et des cliniciens à l’honneur lors du 16e congrès annuel de l’Association européenne pour l’hémophilie et les troubles apparentés (EAHAD)

LACHEN, Suisse, 18 janvier 2023 /PRNewswire/ — Le traitement de remplacement par le facteur VIII est le pilier du traitement des patients atteints d’hémophilie A sévère depuis plus de 30 ans, avec des avantages prouvés en matière de prévention des saignements et de protection de la santé…

KCF Technologies reaches $1 Billion in Customer Savings in CY2022

STATE COLLEGE, Pa., Jan. 18, 2023 /PRNewswire/ — KCF Technologies, a leading provider of machine health optimization technology and services, announced today a major milestone – $1,001,781,030 in tracked customer savings collectively across all industries they served in 2022, bringing…

APRINOIA Therapeutics and ROSS Acquisition Corp II Announce Business Combination Agreement to Create Publicly Listed Company Focused on Neurodegenerative Diseases

ROSS SPAC will issue $280 million of stock for APRINOIA Therapeutics Precision Neurology Company Focused on Developing a Pipeline of Highly Specific Central Nervous System (“CNS”) Diagnostics and Therapeutics, including CNS Protein Degraders Anticipated Proceeds From Transaction Expected…

Former Product Executive from Divvy and Active Angel Investor, Tyler Hogge, Joins Pelion Venture Partners as a Venture Partner

Hogge led the product and risk organizations at Divvy as SVP of Product through its $2.5 billion acquisition by BILL. Prior to Divvy, Hogge led core product teams at Wealthfront, spent time at SaaStr and Andreessen Horowtiz, and led sales for Clearwater Analytics. Since the Divvy…

The Halifax Group Hires Shawn Xiao as Vice President

WASHINGTON, Jan. 18, 2023 /PRNewswire/ — The Halifax Group (“Halifax”), a private equity firm that partners with management to invest in entrepreneurial companies, announced today that it has hired Shawn Xiao as a Vice President. Mr. Xiao, who works in the firm’s Washington, D.C. office,…

Palmer Lake Veterinary Hospital Moves to State-of-the-Art Facility

MONUMENT, Colo., Jan. 18, 2023 /PRNewswire/ — This November, Palmer Lake Veterinary Hospital moved from their old location to a brand new, 7,100 square foot veterinary hospital fully equipped with state-of-the-art fixtures and optimized for efficient workflow. Palmer Lake Veterinary…

« Previous Page — Next Page »